Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

The impact of genetic variability of pharmacogenes as a possible risk factor for adverse drug reactions is elucidated in the EMPAR (Einfluss metabolischer Profile auf die Arzneimitteltherapiesicherheit in der Routineversorgung/English: influence of metabolic profiles on the safety of drug therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fracowiak, Jochen, Huebner, Tatjana, Heß, Steffen, Roethlein, Christoph, Langner, Daria, Schneider, Udo, Falkenberg, Felix, Scholl, Catharina, Linder, Roland, Stingl, Julia, Haenisch, Britta, Steffens, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Consensus Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975744/
https://www.ncbi.nlm.nih.gov/pubmed/35102241
http://dx.doi.org/10.1038/s41397-022-00268-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975744/
https://www.ncbi.nlm.nih.gov/pubmed/35102241
http://dx.doi.org/10.1038/s41397-022-00268-6

Ejemplares similares